Smart acoustic and ultrasonic systems that can adjust and optimise to their environments are changing the way connected ...

The European Medicines Agency is to continue accepting applications for adaptive approval after wrapping up a two-year pilot of the concept. The EMA pitched the pathway as a way for drugmakers to ...

An EMA pilot study looking at progressive licensing of new drugs has found that there are merits to the approach, but further work is needed before the concept can be rolled out across the EU. The EMA ...

LONDON – Pluristem Therapeutics Inc.'s PLX placenta-based cell therapy has been selected for the EMA adaptive pathways pilot, a designation the company said will save a lot of money and cut three to ...